TheEdgeResearch
Home / Stocks / RMSL

REMSleep Holdings, Inc. (RMSL)

OTC Healthcare Medical - Devices
$0.00 ▲ +11.15%
Market Cap
$2.4M
Sector
Healthcare
Industry
Medical - Devices
Beta
-0.18
52-Wk Range
0.0011-0.009
CEO
Sanja Pekovic
Country
US
Currency
USD

REMSleep Holdings, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Blackshear, GA, US. The stock last traded at $0.00, up 11.15% on the session, giving a market capitalisation of $2.4M. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -18062916120.1%. Its beta of -0.18 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
146.45
Price / Book
-19.93
EV / EBITDA
-0.82
Gross margin
-20.1%
Operating margin
-17150.9%
Net margin
-18062916120.1%
Return on equity
Debt / equity
-0.30
Current ratio
0.47
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2009-07-24
Headquarters
Blackshear, GA, US
About REMSleep Holdings, Inc.

REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.

Comparable companies

REMSleep Holdings, Inc. is most often compared with the following Healthcare names:

CBSCCTABFFZMDIDXGIRMEKOSKLLBOPDRXRNVATGIFF
More research on RMSL
RMSL technical analysis RMSL TheEdge Score Compare against peers
Open full interactive analysis & DCF →